Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
阿扎胞苷和维奈克拉对婴儿 KMT2A 重排急性淋巴细胞白血病的临床前疗效揭示了一种新的治疗策略
期刊:Leukemia
影响因子:12.8
doi:10.1038/s41375-022-01746-3
Laurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, Sung K Chiu, Vincent Kuek, Denise Anderson, Grace-Alyssa Chua, Sajla Singh, Joyce Oommen, Emanuela Ferrari, Anastasia M Hughes, Jette Ford, Elena Kunold, Maria C Hesselman, Frederik Post, Kelly E Faulk, Erin H Breese, Erin M Guest, Patrick A
